集團(tuán)介紹
您的位置: 首頁 > 走進(jìn)太極 > 集團(tuán)介紹 > 欄目信息
太極集團(tuán)有限公司（簡稱“太極集團(tuán)”，股票代碼：600129）始建于1972年，2021年完成戰(zhàn)略重組，成為“世界500強(qiáng)”中國醫(yī)藥集團(tuán)有限公司的控股企業(yè)。公司以現(xiàn)代中藥智能制造為主、麻精特色化藥為輔，作為國藥集團(tuán)現(xiàn)代中藥板塊的重要組成部分，致力于傳承創(chuàng)新中醫(yī)藥和發(fā)展現(xiàn)代醫(yī)藥，有13家制藥廠、20多家醫(yī)藥商業(yè)公司，另有以川渝為主陣地的3000多家連鎖藥房，業(yè)務(wù)涵蓋醫(yī)藥研發(fā)、藥品生產(chǎn)、醫(yī)藥商業(yè)、中藥材資源等領(lǐng)域，員工1.3萬人。
公司連續(xù)獲評工信部“中國醫(yī)藥工業(yè)百強(qiáng)企業(yè)”；2016年獲“國家知識產(chǎn)權(quán)示范企業(yè)”稱號；在國際權(quán)威品牌價(jià)值咨詢公司Brand Finance發(fā)布的2023年中國醫(yī)藥品牌價(jià)值排名中位列13位；公司通過了國家工信部“工業(yè)化和信息化兩化融合管理體系”認(rèn)證；公司中藥提取中心通過國家工信部醫(yī)藥產(chǎn)業(yè)數(shù)字化項(xiàng)目技術(shù)評審；公司旗下兩大連鎖藥房品牌“桐君閣大藥房”和“太極大藥房”多次榮獲“中國商業(yè)名牌企業(yè)”、“中國連鎖藥店直營力百強(qiáng)企業(yè)”，在2019-2020年度《中國藥店》價(jià)值榜100強(qiáng)中排名第六，綜合實(shí)力100強(qiáng)中排名第八；公司獲評“2023年度中國非處方藥生產(chǎn)企業(yè)綜合統(tǒng)計(jì)”第二名；2022年3月獲批重慶首個(gè)“國家中醫(yī)藥服務(wù)出口基地”。
1998年，太極集團(tuán)與國內(nèi)外多家院校合作建立國家首批博士后工作站；1999年，太極集團(tuán)技術(shù)中心被認(rèn)定為國家企業(yè)技術(shù)中心。近年來承擔(dān)國家科技部、發(fā)改委、工信部等重大專項(xiàng)項(xiàng)目近40項(xiàng)、省級項(xiàng)目50余項(xiàng)。公司成功研發(fā)新藥40余個(gè)、獲國家新藥證書30余個(gè)、曾獲中國專利金獎(jiǎng)3項(xiàng)。擁有有效授權(quán)專利300件，藥品批文共計(jì)1240個(gè)，其中中藥品種批文690個(gè)、化藥品種批文550個(gè)，醫(yī)保品種739個(gè)、基藥369個(gè)。
公司產(chǎn)品涉及六大治療領(lǐng)域，主要有以藿香正氣口服液、太羅等為代表的消化系統(tǒng)及代謝用藥，以急支糖漿為代表的呼吸系統(tǒng)用藥，以丹參口服液為代表的心血管用藥，以益保世靈為代表的抗感染藥物，以通天口服液、美菲康為代表的神經(jīng)系統(tǒng)用藥，以紫杉醇、補(bǔ)腎益壽膠囊等為代表的抗腫瘤及免疫調(diào)節(jié)藥物等，以及大健康養(yǎng)生產(chǎn)品。公司產(chǎn)品擁有較高的市場占有率，其品牌、品質(zhì)贏得了老百姓的認(rèn)可和信賴。
醫(yī)藥工業(yè)
中藥生產(chǎn)方面，擁有中華老字號“桐君閣”“劍門”和“桐君閣傳統(tǒng)丸劑制作技藝”“太極五子衍宗丸制作技藝”等多項(xiàng)國家級、省市區(qū)級非物質(zhì)文化遺產(chǎn)，擁有年產(chǎn)1億瓶的糖漿劑生產(chǎn)線、年產(chǎn)30億支的口服液生產(chǎn)線、年提取藥材10萬噸的中藥材前處理車間和提取濃縮車間?；幧a(chǎn)方面，擁有西南地區(qū)麻醉藥及精神類藥品定點(diǎn)生產(chǎn)企業(yè)，具有先進(jìn)的緩控釋技術(shù)、速釋技術(shù)、滴丸和緩釋滴丸等技術(shù)。中藥飲片生產(chǎn)方面，擁有年產(chǎn)優(yōu)質(zhì)中藥飲片1500噸的智能化工廠。
醫(yī)藥商業(yè)
公司成功打造了集醫(yī)藥零售、醫(yī)院銷售、零售終端配送、商業(yè)分銷、醫(yī)藥進(jìn)出口、醫(yī)藥電商、中藥經(jīng)營、醫(yī)藥三方物流等多業(yè)態(tài)為一體的大型醫(yī)藥商業(yè)體系，經(jīng)營品規(guī)達(dá)5萬余個(gè)。零售業(yè)務(wù)憑借誠信的經(jīng)營理念、優(yōu)質(zhì)和專業(yè)的服務(wù)贏得了大眾的信賴，綜合競爭力在川渝位居前列。公司設(shè)立有多個(gè)配送中心，總倉儲面積約15萬平方米，具備自有冷鏈配送、廂式配送車200余輛，配送能力輻射終端10萬家以上。公司旗下桐君閣股份有限公司是重慶市醫(yī)藥物資戰(zhàn)略儲備單位，其合作配送單位——桐君閣物流配送有限公司，是重慶市首家擁有醫(yī)藥、器械三方物流雙資質(zhì)的企業(yè)，設(shè)計(jì)倉容100萬件，年吞吐能力達(dá)2000萬件。
中藥資源
以優(yōu)質(zhì)中藥材為導(dǎo)向，堅(jiān)持“道地種植、全程追溯”理念，遵循“三無一全”、“六統(tǒng)一”要求，通過“太極中藥農(nóng)業(yè)全程質(zhì)量追溯平臺”全過程管控藥材質(zhì)量，已建成中藥材規(guī)范化種植基地10多萬畝。半夏、金蕎麥、前胡等單品種植規(guī)模行業(yè)領(lǐng)先。承擔(dān)國家級中藥材種植與科研項(xiàng)目5個(gè)，省級科技攻關(guān)項(xiàng)目8個(gè)。公司多次被評為“農(nóng)業(yè)產(chǎn)業(yè)化國家重點(diǎn)龍頭企業(yè)”。
國際業(yè)務(wù)
緊跟“一帶一路”步伐，積極開拓中醫(yī)藥海外市場，弘揚(yáng)中醫(yī)藥文化。太極藿香正氣口服液、急支糖漿、補(bǔ)腎益壽膠囊、太極天膠、丹參口服液、穿龍骨刺片、超濃縮六味地黃丸等系列太極產(chǎn)品共計(jì)30個(gè)品規(guī)，已在新加坡、馬來西亞、印度尼西亞、泰國、美國、加拿大、俄羅斯、巴基斯坦等幾十個(gè)國家和地區(qū)注冊，獲注冊文號100余個(gè)。
大健康產(chǎn)業(yè)
太極集團(tuán)積極落實(shí)“健康中國”戰(zhàn)略，加快大健康產(chǎn)業(yè)步伐，將中醫(yī)藥文化與生態(tài)養(yǎng)生相結(jié)合，打造大健康產(chǎn)品及全新生態(tài)康養(yǎng)項(xiàng)目。擁有“TAIJI”烏發(fā)露、沐浴露、番茄紅素軟膠囊等大健康產(chǎn)品，并通過太極醫(yī)療養(yǎng)生產(chǎn)業(yè)基地（國藥集團(tuán)國際生命健康城）、武陵山國家森林公園、康定蟲草基地等多個(gè)新理念康養(yǎng)項(xiàng)目逐步構(gòu)建大健康產(chǎn)業(yè)鏈新格局。
初心如磐，駿業(yè)日新。
太極集團(tuán)將秉承“關(guān)愛生命 呵護(hù)健康”的企業(yè)理念，心懷“國藥澤華夏，太極濟(jì)蒼生”的初心使命，遵循“做強(qiáng)做優(yōu)做大醫(yī)藥健康主業(yè)”的目標(biāo)定位，正源出新、精益求精，不斷推進(jìn)中醫(yī)藥現(xiàn)代化，努力打造世界一流的中藥企業(yè)，推動中醫(yī)藥走向世界，為建設(shè)健康中國、實(shí)現(xiàn)中華民族偉大復(fù)興的中國夢貢獻(xiàn)國藥太極力量！
About Us
In 2021, Taiji Group Co., Ltd. (Taiji Group for short, stock code: 600129), whose history could be dated back to 1972, accomplished a strategic restructuring, becoming a member of China National Pharmaceutical Group Co., Ltd.(Sinopharm for short), one of the Fortune Global 500 company.
Taiji Group mainly engages in the intelligent manufacturing of modern Chinese medicine, supplemented by stupefacient and psychotropic drugs. As an important part of Sinopharm's modern Chinese medicine division, Taiji Group is committed to the inheritance and innovation of traditional Chinese medicine and the development of modern Chinese medicine.
Taiji Group owns 13 pharmaceutical factories, more than 20 pharmaceutical commercial companies, two pharmaceutical research institutes, more than 3,000 chain pharmacies mainly based in Sichuan and Chongqing，with 13,000 employees and a full chain mainly covering pharmaceutical research and development, industrial production, pharmaceutical sales and big health industry.
Taiji Group has been consecutively rated as a "Top 100 Pharmaceutical Enterprise in China" by the Ministry of Industry and Information Technology. In 2016, Taiji Group won the title of "National Intellectual Property Model Enterprise". In the China Pharmaceutical Brand Value Ranking 2023 released by Brand Finance, an authoritative international brand value consulting company, Taiji Group ranked 13th. Taiji Group has earned the "Industrialization-Informatization Integration Management System" certification by the Ministry of Industry and Information Technology. The TCM Extraction Center has passed the technical review by the Ministry of Industry and Information Technology as a pharmaceutical industry digitization project.
Two chain pharmacy brands “TongJunGe Pharmacy” and “Taiji Pharmacy” have won titles of “China's Famous Commercial Enterprise” and “Top 100 Chain Pharmacy in China by Direct Sales Strength” several times， ranking 6th in the Top 100 Value List and ranking 8th in the Top 100 Comprehensive Strength List of 《China Drug Store》 in 2019-2020 . Taiji Group won second place in the "Comprehensive Statistics of China's OTC Drug Manufacturers in 2023". In March 2022, Taiji Group was approved as the first "National TCM Service Export Base" in Chongqing.
In 1998, Taiji Group worked with domestic and foreign universities to establish the first batch of post-doctoral workstations in China. In 1999, Taiji Group?s Technology Center was recognized as a National Enterprise Technology Center. In recent years, Taiji Group has undertaken nearly 40 major special projects of the Ministry of Science and Technology, the National Development and Reform Commission and the Ministry of Industry and Information Technology, and more than 50 provincial projects. Taiji Group has successfully developed more than 40 new drugs, obtained more than 30 national new drug certificates, and won 3 China Patent Gold Awards. Taiji Group holds 300 valid authorized patents and a total of 1,240 drug approvals, including 690 approvals for TCM drugs, 550 approvals for chemical drugs, 739 approvals for drugs covered by medical insurance, and 369 approvals for essential drugs.
Taiji products cover six therapeutic areas, including digestive system and metabolic system drugs represented by Huo Xiang Zheng Qi Kou Fu Ye and Rosiglitazone Sodium Tablets; Respiratory system drugs represented by Ji Zhi Tang Jiang; Cardiovascular drugs represented by Dan Shen Kou Fu Ye；Anti-infective drugs represented by Ceftizoxime Sodium for Injection；Nervous system drugs represented by Tong Tian Kou Fu Ye and Morphine Hydrochloride Sustained-Release Tablets；Antitumor and immunomodulatory drugs represented by Paclitaxel Injection and Bu Shen Yi Shou Jiao Nang, as well as health products. Taiji products have a high market share. The brand and quality have won people's recognition and trust.
Pharmaceutical Manufacturing
In terms of TCM production, Taiji Group owns China Time-Honored Brand "TongJunGe", and a number of national, provincial, municipal, district items of intangible cultural heritage such as the "TongJunGe traditional pill production technique", in addition to a syrup production line with an annual output of 100 million bottles, an oral solution production line with an annual output of 2 billion bottles, a TCM material pre-treatment workshop and extraction and concentration workshop with an annual output of 100,000 tons. In terms of chemical drug production, Taiji Group owns a designated manufacturer of stupefacient and psychotropic drugs in southwest China, which has advanced controlled slow release technology, rapid release technology, guttate pill and slow release guttate pill technologies. In terms of TCM decoction pieces production, we have an intelligent factory with an annual output of 1,500 tons of high-quality TCM decoction pieces.
Pharmaceutical Sales
Taiji Group has successfully built a large pharmaceutical sales system integrating pharmaceutical retail, hospital sales, retail terminal distribution, commercial distribution, pharmaceutical import and export, pharmaceutical e-commerce, TCM sales, 3rd-party pharmaceutical logistics and other services for more than 50,000 product specifications. By virtue of integrity, high quality and professional service, the retail business has won the trust of the public, with comprehensive competitiveness among the top drug vendors in Sichuan and Chongqing. Taiji Group has set up a number of distribution centers, with a total storage area of about 150,000 square meters, more than 200 vehicles for distribution and cold chain distribution. The distribution capacity reaches more than 100,000 terminals. Taiji Group’s subsidiary such as Tong Jun Ge Co., Ltd., is a strategic reserve unit for medical supplies in Chongqing; Tong Jun Ge Logistics & Distribution Co., Ltd., is the first qualified 3rd-party logistics enterprise for medicine and medical instruments in Chongqing, with a designed warehouse capacity of 1 million pieces and an annual throughput capacity of 20 million pieces.
TCM Resources
Focusing on high-quality TCM materials, Taiji Group insists on “genuine planting, full traceability?, follow the requirements of “sulfur-free, aflatoxin-free, pollution-free, whole-process traceability? and ?six unification”, and control the quality of TCM materials throughout the production process through "Taiji TCM Agriculture Full Quality Traceability Platform". Taiji Group has built more than 100,000 mu of standard planting bases for TCM materials. The planting scale of Pinellia ternata, Fagopyrum cymosum, Radix Peucedani and other single varieties is leading in the industry. We have undertaken 5 national TCM material planting and scientific research projects and 8 provincial key scientific and technological research projects. Our company has been rated as a "National Key Leading Enterprise for Agricultural Industrialization" for several times.
International Business
Closely following the Belt and Road Initiative, Taiji Group actively explores overseas markets for TCM and promotes TCM culture. Taiji product series with 30 product specifications, including Huo Xiang Zheng Qi Kou Fu Ye、Ji Zhi Tang Jiang、Bu Shen Yi Shou Jiao Nang、Taiji E Jiao、Dan Shen Kou Fu Ye、Chuan Long Gu Ci Pian、Liu Wei Di Huang Wan (Concentrated Pills), have been registered in dozens of countries and territories, such as Singapore, Malaysia, Indonesia, Thailand, the United States, Canada, Russia, Pakistan, with 100 registration numbers.
Big Health Industry
Taiji Group actively implements the "Healthy China" strategy, speeds up its pace in the big health industry, combines TCM culture with ecological health preservation, and creates health products and new ecological health care projects. Taiji health products include “TAIJI”Shampoo,?TAIJI?Shower Gel, Lycopene Soft Capsule and so on. We are forming a new pattern in the big health industry chain through a number of new concept health care projects, such as Taiji Health Care Industry Base (Sinopharm International Life and Health City), Wuling Mountain National Forest Park and Kangding Cordyceps Base.
Unshaken Original Aspiration, Constant Business Progress
Guided by the core value of “All for Health,Health for All”, Taiji Group keeps the original aspiration of “TCM for Huaxia, Taiji for People” in mind, stick to the target position of "stronger, better and bigger pharmaceutical and health core business". Taiji Group innovates on heritage, seek for greater perfection, constantly promote the modernization of TCM, strives to build a world-class TCM enterprise, promote the internationalization of TCM., and contributes to the building of a healthy China and the realization of the Chinese dream of the great rejuvenation of the Chinese nation.
太極集團(tuán)
